12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Persistent negative symptoms in individuals at Ultra High Risk for psychosis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Persistent negative symptoms (PNS) defined as negative symptoms that persist for at least six months in the absence of high levels of positive, depressive and extrapyramidal symptoms, are evident early in the course of schizophrenia from the first episode of psychosis. However, their presence even earlier in the illness, in those at Ultra High Risk of psychosis, has not been investigated. In this study, we examined the prevalence, baseline correlates and outcome of PNS in 363 Ultra High Risk individuals. Assessments were conducted at baseline and 2–14 years later (mean follow up time 7.4 years). Baseline assessments included demographic, clinical and neurocognitive measures, which were repeated at follow up. The prevalence of PNS in the UHR group was 6.1%. Poor premorbid social adjustment, deficits in verbal fluency and childhood maltreatment, specifically emotional neglect, were evident at baseline in the PNS group compared to the group without PNS. PNS were associated with poor psychosocial functioning and deficits in processing speed at follow up. Our findings suggest that PNS can be detected early, allowing for the identification of a subset of Ultra High Risk patients who are likely to have poor outcome. These individuals could be the target for specific intervention. Further research is needed into the pathophysiology of these PNS to develop specific interventions.

          Related collections

          Most cited references53

          • Record: found
          • Abstract: not found
          • Article: not found

          Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Development and validation of a brief screening version of the Childhood Trauma Questionnaire.

            The goal of this study was to develop and validate a short form of the Childhood Trauma Questionnaire (the CTQ-SF) as a screening measure for maltreatment histories in both clinical and nonreferred groups. Exploratory and confirmatory factor analyses of the 70 original CTQ items were used to create a 28-item version of the scale (25 clinical items and three validity items) and test the measurement invariance of the 25 clinical items across four samples: 378 adult substance abusing patients from New York City, 396 adolescent psychiatric inpatients, 625 substance abusing individuals from southwest Texas, and 579 individuals from a normative community sample (combined N=1978). Results showed that the CTQ-SF's items held essentially the same meaning across all four samples (i.e., measurement invariance). Moreover, the scale demonstrated good criterion-related validity in a subsample of adolescents on whom corroborative data were available. These findings support the viability of the CTQ-SF across diverse clinical and nonreferred populations.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              The NIMH-MATRICS consensus statement on negative symptoms.

                Bookmark

                Author and article information

                Contributors
                Journal
                Schizophr Res
                Schizophr. Res
                Schizophrenia Research
                Elsevier Science Publisher B. V
                0920-9964
                1573-2509
                1 April 2019
                April 2019
                : 206
                : 355-361
                Affiliations
                [a ]Division of Psychology and Mental Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
                [b ]Greater Manchester Mental Health NHS Trust, Manchester, UK
                [c ]Orygen, The National Centre of Excellence in Youth Mental Health, Australia
                [d ]Centre for Youth Mental Health, The University of Melbourne, Australia
                [e ]School of Psychology, University of Birmingham, UK
                [f ]Telethon Kids Institute, Australia
                Author notes
                [* ]Corresponding author at: Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Oxford Rd, Manchester M13 9PL, UK. alison.yung@ 123456manchester.ac.uk
                Article
                S0920-9964(18)30621-2
                10.1016/j.schres.2018.10.019
                6542412
                30482643
                81d6eef6-68fe-4450-a1e4-8c60c42ca0f0
                © 2018 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 21 May 2018
                : 16 October 2018
                : 20 October 2018
                Categories
                Article

                Neurology
                negative symptoms,clinical high risk,at risk mental state,prodrome,neurocognition,childhood maltreatment

                Comments

                Comment on this article